VS
Varudhappan Sugavanan
About Varudhappan Sugavanan
Data last updated:
Varudhappan Sugavanan is a Designated Partner at Spaderan Pharmaceuticals India Llp (since 2026). The companies operate in Hospitality & Wellness. Earlier, Varudhappan Sugavanan was a Designated Partner at V6 Garden Inn Llp (2023–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spaderan Pharmaceuticals India Llp ADA-2586 | Designated Partner | 20 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| V6 Garden Inn Llp ACD-4903 | Designated Partner | 18 Oct 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Varudhappan Sugavanan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Varudhappan Sugavanan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Varudhappan Sugavanan
Varudhappan Sugavanan currently holds 1 directorship: Spaderan Pharmaceuticals India Llp (Designated Partner, since 20 Jul 2026).
Varudhappan Sugavanan was first appointed on 18 Oct 2023 as Designated Partner at V6 Garden Inn Llp. The most recent appointment on record is 20 Jul 2026 at Spaderan Pharmaceuticals India Llp.
Varudhappan Sugavanan held 1 earlier board appointment: V6 Garden Inn Llp (Designated Partner, 18 Oct 2023 to 01 Feb 2025).
The current boards of Varudhappan Sugavanan's companies include Nantha Kumar (Spaderan Pharmaceuticals India Llp), Palani Kumar (Spaderan Pharmaceuticals India Llp), Sureshbabu (Spaderan Pharmaceuticals India Llp), Mallikarjunan Praveen (Spaderan Pharmaceuticals India Llp), Manoharan Anand (Spaderan Pharmaceuticals India Llp), Murugesan Deepak (Spaderan Pharmaceuticals India Llp), among others.